C07K 14/11
Orthomyxoviridae
Official title: Orthomyxoviridae, e.g. influenza virus
C07K14/11 (Orthomyxoviridae) appears on 108 US grants and 168 published applications in this corpus.
Search patents in C07K- Granted patents
- 108
- Published applications
- 168
- Assignees
- 89
- Inventors
- 314
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 3 |
| 2011 | 0 | 3 |
| 2012 | 1 | 2 |
| 2013 | 5 | 17 |
| 2014 | 2 | 2 |
| 2015 | 10 | 10 |
| 2016 | 8 | 9 |
| 2017 | 5 | 8 |
| 2018 | 9 | 15 |
| 2019 | 11 | 20 |
| 2020 | 8 | 5 |
| 2021 | 7 | 14 |
| 2022 | 8 | 9 |
| 2023 | 7 | 14 |
| 2024 | 8 | 13 |
| 2025 | 11 | 4 |
| 2026 | 8 | 15 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Mutant influenza B/Victoria lineage virus hemagglutinin proteins6 Oct 2026US 12,752,001 B2ModernaTX, Inc.
- Vaccine using M2/BM2-deficient influenza vectors8 Sep 2026US 12,728,160 B2FluGen, Inc.
- Fusion protein comprising BP26 and antigenic polypeptide23 Jun 2026US 12,662,515 B2Korea Advanced Institute of Science and Technology
- Targeted antigen delivery system and uses thereof26 May 2026US 12,636,378 B2SRI International
- Swine influenza A virus vaccine comprising a nucleic acid construct having a specific order of genes19 May 2026US 12,630,592 B2Intervet Inc.
- Universal influenza mrna vaccine and use thereof10 Sep 2026US 2026/0263585 A1Shanghai Institute of Biological Products Co., Ltd.
- Nucleic acid influenza vaccines and respiratory virus combination vaccines27 Aug 2026US 2026/0248903 A1ModernaTX, Inc.
- Swine influenza a virus vaccine comprising a nucleic acid construct having a specific order of genes30 Jul 2026US 2026/0217771 A1Intervet Inc.
- Tet-r expression cassettes and cell lines16 Jul 2026US 2026/0201417 A1Cevec Pharmaceuticals GmbH
- Influenza virus backbone2 Jul 2026US 2026/0185059 A1FluGen, Inc.
Most cited
By later US patents
- Influenza hemagglutinin and neuraminidase variants31US 8,574,593 B2MedImmune, LLC · 2013
- Influenza virus vaccine and uses thereof27US 9,708,373 B2Icahn School of Medicine at Mount Sinai · 2017
- Vaccines for use in the prophylaxis and treatment of influenza virus disease17US 9,701,723 B2Icahn School of Medicine at Mount Sinai · 2017
- Influenza virus vaccines and uses thereof14US 10,179,806 B22019
- Compositions that include hemagglutinin14US 8,420,102 B2VaxInnate Corporation · 2013